Fosinopril Sodium
- Product NDC
- 71335-0873
- 11-digit product format
- 713350873
- Labeler code
- 71335
- Product ID
- 71335-0873_066c5c5e-f975-45be-9e28-659b726a6ba7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fosinopril Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA076139
- Marketing category
- ANDA
- Marketing start
- 2003-12-01
- Marketing end
- 0000-00-00
- Substance
- FOSINOPRIL SODIUM
- Active strength
- 10 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71335-0873-1 | 2021-04-29 | C162847 | 48780-1 | 9d75b9cf-e036-f424-e053-dadaa90a57ce | af013785-ce3c-41ab-bfc3-28349bd55a21 |
| 71335-0873-2 | 2021-04-29 | C162847 | 48780-1 | 9d75b9cf-e036-f424-e053-dadaa90a57ce | af013785-ce3c-41ab-bfc3-28349bd55a21 |
| 71335-0873-3 | 2021-04-29 | C162847 | 48780-1 | 9d75b9cf-e036-f424-e053-dadaa90a57ce | af013785-ce3c-41ab-bfc3-28349bd55a21 |
| 71335-0873-4 | 2021-04-29 | C162847 | 48780-1 | 9d75b9cf-e036-f424-e053-dadaa90a57ce | af013785-ce3c-41ab-bfc3-28349bd55a21 |
| 71335-0873-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-e036-f424-e053-dadaa90a57ce | af013785-ce3c-41ab-bfc3-28349bd55a21 |
| 71335-0873-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-e036-f424-e053-dadaa90a57ce | af013785-ce3c-41ab-bfc3-28349bd55a21 |
| 71335-0873-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-e036-f424-e053-dadaa90a57ce | af013785-ce3c-41ab-bfc3-28349bd55a21 |
| 71335-0873-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-e036-f424-e053-dadaa90a57ce | af013785-ce3c-41ab-bfc3-28349bd55a21 |